$SUPN
Supernus Pharmaceuticals, Inc.
XNAS•Health Care•Pharmaceutical Preparations
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateSupernus Pharmaceuticals, Inc.
XNAS•Health Care•Pharmaceutical Preparations
Why is SUPN down today? It is at $42.00 (-2.14%), and our scanner flagged it 38 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment SUPN spikes, and full due diligence on SUPN — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $SUPN 38 times in the last 30 days. Create a free account to track $SUPN, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on SUPN from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for SUPN today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Dec Timothy C Officer | Sold (automatic/other) | -604 | sold 6.2% | 9K | $28K at $46.57 | Aug 12, 26 |
Dec Timothy C Officer | Other | 1K | added 15% | 10K | n/a | Aug 12, 26 |
Bhatt Padmanabh P. Officer | Sold (automatic/other) | -1K | sold 5.8% | 19K | $54K at $46.57 | Aug 12, 26 |
Bhatt Padmanabh P. Officer | Other | 3K | added 14% | 20K | n/a | Aug 12, 26 |
Rubin Jonathan Officer | Sold (automatic/other) | -363 | sold 2.5% | 14K | $17K at $46.57 | Aug 12, 26 |
Rubin Jonathan Officer | Other | 750 | added 5.5% | 14K | n/a | Aug 12, 26 |
Khattar Jack A. Officer | Sold (automatic/other) | -13K 0.02% of company | sold 1.0% | 1.26M | $589K at $46.57 | Aug 12, 26 |
Khattar Jack A. Officer | Other | 30K 0.05% of company | added 2.4% | 1.27M | n/a | Aug 12, 26 |
Mottola Frank Officer | Sold (automatic/other) | -797 | sold 3.9% | 20K | $37K at $46.57 | Aug 12, 26 |
Mottola Frank Officer | Other | 2K | added 8.8% | 20K | n/a | Aug 12, 26 |
Bhatt Padmanabh P. Officer | Sold (automatic/other) | -7K 0.01% of company | sold 30% | 17K | $359K at $49.55 | Mar 18, 26 |
Bhatt Padmanabh P. Officer | Other | 7K 0.01% of company | added 43% | 24K | $286K at $39.40 | Mar 18, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on SUPN from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for SUPN today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
SUPN last traded at $42.00, down 2.14% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Supernus Pharmaceuticals, Inc. (SUPN) is next expected to report earnings on Tuesday, November 3, 2026, about 44 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The SUPN Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged SUPN 38 times in the last 30 days.
SUPN (Supernus Pharmaceuticals, Inc.) trades on XNAS, with a market cap of about $2.44B in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge SUPN for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$SUPN discussion
Sign in to ask a question or join the discussion.